Pharmabiz

Ascletis Pharma reports positive results from US phase II study of ASC30, an oral small molecule GLP-1R agonist, to treat type 2 diabetes mellitus

Ascletis Pharma reports positive results from US phase II study of ASC30, an oral small molecule GLP-1R agonist, to treat type 2 diabetes mellitus: Hong Kong Friday, October 30, 2 ...
Pharmabiz

Strides Pharma Science clocks in Q2 revenues at Rs. 1,429.7 crore with growth of 17% YoY

Strides Pharma Science clocks in Q2 revenues at Rs. 1,429.7 crore with growth of 17% YoY: Our Bureau, Bengaluru Friday, October 30, 2026, 12:30 Hrs [IST] Strides Pharma Science in ...
Pharmabiz

Bayer launches Diabetes Grab-A-Thon awareness

Our Bureau, Mumbai Friday, October 30, 2026, 12:50 Hrs [IST] Bayer has launched its ‘Diabetes Grab-A-Thon’ awareness initiative ...
Pharmabiz

Indegene Q2 PAT stood at Rs. 1,123 million

The company's revenue stood at Rs. 11,223 million ($117.5 million), up 39.5% YoY, while PAT Rs. 1,123 million at 10.0% margin, up 10.0% YoY “Extending our strong start to FY27, Q2 revenue grew 5.6% ...
Pharmabiz

Sobi to present data from pivotal phase 3 REDUCE-2 study of pozdeutinurad at ACR Convergence 2026

Sobi to present data from pivotal phase 3 REDUCE-2 study of pozdeutinurad at ACR Convergence 2026: Stockholm, Sweden Friday, October 30, 2026, 11:00 Hrs [IST] Sobi, a global bioph ...
Pharmabiz

US FDA approves Abbott’s Amplatzer Paraclose PVL Occluder to treat leaks after heart valve replacement without additional surgery

US FDA approves Abbott’s Amplatzer Paraclose PVL Occluder to treat leaks after heart valve replacement without additional surgery: Abbott Park, Illinois Friday, October 30, 2026 ...
Pharmabiz

RPG Life Sciences Q2 revenue up 16.5%

RPG Life Sciences sustained strong growth momentum in Q2 crossing the Rs. 200 crore quarterly revenue milestone. Revenue from operations grew 16.5% to Rs. 211.6 crore. The acquired sites contributed ...
Pharmabiz

GHIT announces total investment of approx. USD 6.8 mn in product development for malaria, NTDs and other emerging & re-emerging infectious diseases such as Ebola disease

GHIT announces total investment of approx. USD 6.8 mn in product development for malaria, NTDs and other emerging & re-emerging infectious diseases such as Ebola disease: Tokyo Fr ...
Pharmabiz

MSD’s Capvaxive gets Health Sciences Authority of Singapore approval to prevent invasive pneumococcal disease and pneumococcal pneumonia in adults

MSD’s Capvaxive gets Health Sciences Authority of Singapore approval to prevent invasive pneumococcal disease and pneumococcal pneumonia in adults: Singapore Friday, October 30, ...
Pharmabiz

Newer formats like gummies other than tablets or capsules in iron supplementation will enhance patient centricity: Expert

Newer formats like gummies other than tablets or capsules in iron supplementation will enhance patient centricity: Expert: Shardul Nautiyal, Mumbai Friday, October 30, 2026, 08:00 ...
Pharmabiz

NCISM opens application window for new PG courses and raise of intake for year 2027-28

NCISM opens application window for new PG courses and raise of intake for year 2027-28: Gireesh Babu, New Delhi Friday, October 30, 2026, 08:00 Hrs [IST] The National Commission f ...
Pharmabiz

Indian hospitals turn to telesurgery to bridge geographical gaps for access to surgical expertise

Indian hospitals are using telesurgery to bring specialist surgical expertise to patients across geographical barriers. These are going on across the advanced medical centres in the country. Dr.